KT-621 Week 16 EASI-75 advantage over placebo Odds · Initial disclosure by Dec 31, 2026
| Outcome | Chance | Odds | 24h |
|---|---|---|---|
| Above 20.0 pp | 96% | -2400 | ▲ 96 |
| Above 25.0 pp | 96% | -2400 | ▲ 96 |
| Above 30.0 pp | 55% | -122 | ▲ 55 |
| Above 35.0 pp | 44% | +130 | — |
| Above 40.0 pp | 21% | +376 | ▲ 30 |
We may earn a commission if you sign up or trade through links to venues. It never changes the prices or rankings we show. 18+ (21+ where required). Only trade where prediction markets are legal for you. Gambling problem? Call or text 1-800-GAMBLER. How we make money
Resolution rules
If the difference between KT-621’s and placebo’s Week 16 EASI-75 response rates in the Phase 2b BROADEN2 trial (NCT07217015), as reported in the Initial Disclosure on or before Dec 31, 2026 at 11:59:59 PM ET, is above 20.0 percentage points, then the market resolves to Yes.
Source: Kalshi. The venue's rules are final.
FAQ
How are prediction market odds calculated?
Each contract pays $1 if the outcome happens and $0 if it doesn't, so its price is the market's implied probability: a 60¢ contract means roughly a 60% chance. We show the last trade, or the midpoint between the best bid and ask when the order book is tight.
When does this market close?
Kalshi lists Jan 1, 2027 as the end date. It can close earlier if the outcome is decided.
Where can I trade on KT-621 Week 16 EASI-75 advantage over placebo?
This market trades on Kalshi. Availability depends on where you live: Kalshi is a CFTC-regulated US exchange, while Polymarket's international site isn't available to US users (Polymarket US is a separate app). You must be 18 or older.